The French scientists concluded, “This study supports the use of immunomodulatory drugs such as ivermectin, to improve the clinical condition of SARS-CoV-infected patients.”
The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.
Dr. Risch gives a succinct history of the politics of hydroxychloroquine and other useful existing medicines in the USA, which has had global effect, as many countries look to the USA for guidance. Corruption and manipulation from behind the scenes around the world are brought to the surface for scrutiny.
Over 10,000 patients,a fatality rate more than 97% LOWER than France’s – an exceptional case for early treatment with a drug regimen including HCQ & AZM.
“The Minister of Health, Marcelo Queiroga, has announced that he will soon launch a protocol of drugs to be used in the treatment against Covid-19. ”
This guide, which should guide health workers, has, as likely drugs, hydroxychloroquine and ivermectin.
HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 235 studies to date is estimated to be 1 in 6 quadrillion (p = 0.00000000000000018).
Early treatment is most successful, with 100% of 29 studies reporting a positive effect (13 statistically significant in isolation) and an estimated reduction of 65% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.35 [0.25-0.50].
92% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.0017.
It is high time to open our eyes, to hold our governments to account, and to fundamentally reform a system that has been misled by the interests of the all-powerful pharmaceutical industry. ”
Source: The New American Author: Annalisa Pesek Calls are increasing for investigations into Dr. Anthony Fauci’s intentional suppression of inexpensive and easily accessible, life-saving treatments for COVID-19.
The primary effect of the article was likely to further ingrain a partisan association with the subject matter, along with the subtext, “Whatever good SCIENCE exists, it can only be on our side [so you won’t need to think any more about it].”
While HCQ looks very safe overall for COVID-19 patients, it looks safest when used as a prophylactic or therapeutic for early stage COVID-19 patients, once again affirming the Primary HCQ Hypothesis as the strongest version of the HCQ Hypothesis.
Source: Rounding the Earth Author: Mathew Crawford The story of why hydroxychloroquine (HCQ) has not been used broadly in most Western nations (primarily in the
Portuguese doctors reacted: since the prescription of hydroxychloroquine was forbidden to them, they fell back on ivermectin and administered it more and more massively.
Antiviral therapy is only of interest during the early and intermediate viral phase when the virus is present and replicates, and is of no use during the late inflammatory phase (cytokine storm). Most therapeutic trials, unfortunately, have been carried out in hospitalized patients, which is to say probably often too late, because the patients are in the early inflammatory phase.
India has conquered the disease with hydroxychloroquine and ivermectin, uses a traditional vaccine, exports experimental vaccines for these idiotic Westerners … There are 1,230 deaths per million inhabitants over 65 (six times less than in France). If we had listened to Raoult and followed the Indian model, today we would have 500 cases of covid per day and 75,000 fewer deaths …
Early treatment intervention with hydoxychloroquine & Ivermectin appears to have played a major role in control in India, precipitating local herd immunity.
On face, it certainly appears that complete silence in the public sphere about hydroxychloroquine’s potential was coordinated by powerful media forces.
The Recovery study therefore has no interest and does not allow us to deduce anything concerning the effect of hydroxychloroquine on COVID-19. This study most certainly killed patients.
The recourse to the treatment with hydroxychloroquine advocated by Professor Raoult would have made it possible to greatly reduce the number of deaths and to avoid the appalling present situation.
Ivermectin: There is a technique of discrediting which is all the rage, always to manipulate: to criticize the form, to make forget the main one: the result. Virtually all of the studies cited by the paper are 95% criticized on form and not on substance, leading to the conclusion, despite results that even a 5-year-old would find obvious, that there is insufficient evidence. If, one day, public domain Ivermectin becomes THE drug against Sars-Cov-2, that will result in billions of losses for the global pharmaceutical industry.
With such a rate of contamination, we are faced with a scenario of collective quasi-immunity managed with a broad prescription of early and prophylactic treatment based on hydroxychloroquine. With a contamination rate of 56%, mortality is 549 people per million inhabitants. Last December, the Institut Pasteur estimated the rate of the French population to be contaminated at 11.3% [1]. Mortality in France is 1200 [2] people per million inhabitants. The population of Delhi is five times more contaminated with mortality more than two times lower compared to France. The case fatality rate with early treatment in Delhi, which is 0.1%, is close to the rate estimated by Professor Raoult in the case of early treatment.
The British Recovery study testing HCQ in patients with COVID-19 used very high doses of hydroxychloroquine, doses that we can qualify as dangerously toxic.
The dose used in the RECOVERY trial, arouses concern because it may have been a disease-aggravating factor negating the therapeutic effect.
The Marseille professor explained himself in an interview with Figaro Magazine on the effectiveness of hydroxychloroquine, conflicts of interest in the scientific community, and the decision taken by Emmanuel Macron not to reconfine.
Source: Reviews in Cardiovascular Medicine Peter A. McCullough, Paul E. Alexander, Robin Armstrong, Cristian Arvinte, Alan F. Bain, Richard P. Bartlett, Robert L. Berkowitz, Andrew
Source: ivmmeta.com Figure 1. A. Random effects meta-analysis excluding late treatment. Simplified dosages are shown for comparison, these are the total dose in the first two days
Hydroxychloroquine is an effective molecule against COVID-19 infection, many RCTs and observational studies, affirmed the benefits on virological clearance.
No cases of sudden death were observed. From publication, we have treated 3,119 patients with HCQ-AZ for at least three days.
While Professor Raoult was testing, isolating and treating his patients, the government decided to send the patients home, without care and with Doliprane for only treatment!
This report forms the scientific basis for the decision to authorise hydroxychloroquine in the treatment of Covid-19 in the early phase of the disease.
Source: Filipe Rafaeli Author: Filipe Rafaeli Read PART ONE here Scientists have already discovered what to do for the hydroxychloroquine to work also in critically
Source: Filipe Rafaeli Author: Filipe Rafaeli If you don’t want to die in this pandemic, read it to the end! Here I do a historical
Source: HCQMeta.com HCQ is effective for COVID-19 when used early: meta-analysis of 156 studies (Version 28, December 4, 2020) • HCQ is effective for COVID-19.
Source: Science Direct Tran Duc Anh Ly, Didier Zanini, Vincent Laforge, Sylvie Arlotto, Stephanie Gentile, Helene Mendizabal, Michael Finaud, David Morel, Olivier Quenette, Priscilla Malfuson-Clot-Faybesse,
Source: Le Point Mister President, Please allow me to add my voice, not to the concert of invective triggered by your decisions of October 28 , but
Source: ACTU Toulouse Author: Hugues-Olivier Dumez Philippe Douste-Blazy is the author of a book against the State facing the crisis. In an interview for Actu Toulouse,
We should learn from the countries that have been using the drug. The dramatic fall in death rates that occurred after hydroxychloroquine treatment was initiated in countries like India, Brazil and Ecuador can no longer be ignored. To do so, and to continue to interfere with a doctor’s right to prescribe HCQ to their patients, is reckless and immoral.
Source: Kristian Francisco Milla Nielsen Author: Kristian Francisco Milla Nielsen In most of the western world, two drugs are used in the fight against covid-19.
Source: Caducee.net In a document posted on the Internet site of the IHU Méditerranée infection by Pr Didier Raoult, we discover a letter signed by
Source: Covexit In a video update released today, Professor Didier Raoult indicated he released a copy of a letter by the pharmaceutical company SANOFI to
While numerous studies have now proven this to be so, and the practical experiences of several doctors with numerous patients have shown that, as part of a package of quality outpatient care, the drug can play an important role in reducing the need for hospitalization and the mortality risk.
